文献速递造血干细胞移植与细胞治疗血栓与止血

CD40L单核苷酸多态性预测异基因干细胞移植后内皮并发症与死亡

Single Nucleotide Polymorphisms in CD40L Predict Endothelial Complications and Mortality After Allogeneic Stem-Cell Transplantation.
PubMed 文献 · J Clin Oncol · 2018-01-25

在294例未接受他汀类内皮预防(SEP)的异基因干细胞移植受者中分析CD40L三个SNP与移植相关血栓性微血管病、总体非复发死亡(NRM)及急性GVHD后NRM的关联,rs3092936 CC/CT基因型与上述风险升高相关;该基因型与高危THBD SNP基本互斥,SEP可完全消除高危CD40L及THBD SNP的影响。

要点

  • rs3092936 CC/CT基因型与移植相关血栓性微血管病风险升高相关(P=.001)。
  • rs3092936 CC/CT基因型与总体NRM(P=.03)及急性GVHD后NRM(P=.01)风险升高相关。
  • SEP完全消除了高危CD40L及THBD SNP对死亡率的影响(P=.40)。

核心结论

  • 移植前可通过受者基因组中的遗传标志物预测内皮并发症风险升高。
  • 接受SEP的患者死亡率风险恢复正常,提示可能克服高危基因型的负面影响,但需进一步临床验证。

研究设计与样本

  • 在294例未接受他汀类内皮预防(SEP)的异基因干细胞移植受者中分析CD40L三个SNP(rs3092920、rs3092952、rs3092936)与移植相关血栓性微血管病、总体NRM及急性GVHD后NRM的关联。
  • 将显著基因型与已确立的THBD基因多态性进行比较,并在一个未接受SEP的独立队列及另外344例接受SEP的患者中验证。

主要发现

  • rs3092936 CC/CT基因型与移植相关血栓性微血管病风险升高相关(P=.001)。
  • rs3092936 CC/CT基因型与总体NRM风险升高相关(P=.03)。
  • rs3092936 CC/CT基因型与急性GVHD后NRM风险升高相关(P=.01)。
  • rs3092936 CC/CT基因型与高危THBD SNP基本互斥。
  • 在未接受SEP的训练队列中,CD40L与THBD SNP均预测不良总生存(OS,P=.04)和总体NRM(P<.001);在未接受SEP的验证队列中,OS(P=.01)和NRM(P=.001)结果相似;SEP完全消除了高危CD40L及THBD SNP的影响(P=.40)。

局限性

  • 作者指出SEP克服高危基因型负面影响的结果需进一步临床验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Purpose Endothelial vulnerability is a potential risk factor for complications after allogeneic stem-cell transplantation (alloSCT). The CD40/CD40 ligand (CD40L) axis contributes to inflammatory diseases and is upregulated in endothelial cells upon activation, suggesting a role in alloSCT biology. Here, we studied single nucleotide polymorphisms (SNPs) in the CD40L gene in recipients of alloSCT. Patients and Methods Three CD40L SNPs (rs3092920, rs3092952, rs3092936) were analyzed for association with transplant-associated thrombotic microangiopathy, overall nonrelapse mortality (NRM), and NRM after acute graft-versus-host disease in 294 recipients of alloSCT without statin-based endothelial prophylaxis (SEP). The significant genotype was then put into perspective with established thrombomodulin ( THBD) gene polymorphisms. Findings were validated in an independent cohort without SEP and in an additional 344 patients who received SEP. Results The rs3092936 CC/CT genotype was associated with an increased risk of transplant-associated thrombotic microangiopathy ( P = .001), overall NRM ( P = .03), and NRM after acute graft-versus-host disease ( P = .01). The rs3092936 CC/CT genotype was largely mutually exclusive of high-risk THBD SNPs. Both CD40L and THBD SNPs predicted adverse overall survival (OS) and overall NRM to a similar extent in training cohort (OS, P = .04; NRM, P < .001) and validation cohort (OS, P = .01; NRM, P = .001) without SEP. In contrast, SEP completely abolished the influence of the high-risk CD40L and THBD SNPs ( P = .40). Conclusion An increased risk of endothelial complications can be predicted before alloSCT by genetic markers in the recipient's genome. The normalization of mortality risks in patients treated with SEP suggests a way of overcoming the negative effect of high-risk genotypes and warrants further clinical validation.

来源:J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. Rachakonda SP, Dai H, Penack O, et al. Single Nucleotide Polymorphisms in CD40L Predict Endothelial Complications and Mortality After Allogeneic Stem-Cell Transplantation. J Clin Oncol. 2018. PMID: 29369699. doi:10.1200/JCO.2017.76.4662

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。